Bioharvest Sciences (BHST) Cash & Equivalents (2023 - 2025)

Bioharvest Sciences' Cash & Equivalents history runs 3 years deep, the most recent figure standing at $23.0 million for Q4 2025.

• In Q4 2025, Cash & Equivalents rose 863.39% year-over-year to $23.0 million; the TTM figure through Dec 2025 stood at $23.0 million (up 863.39% YoY), while the FY2025 annual figure was $23.0 million, up 863.39% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $23.0 million, up from $11.0 million in the prior quarter.
• The five-year high for Cash & Equivalents was $23.0 million in Q4 2025, with the low at $2.4 million in Q1 2024.
• The 3-year median for Cash & Equivalents is $3.7 million (2025), against an average of $6.6 million.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents sank 55.37% in 2024, then surged 863.39% in 2025.
• Bioharvest Sciences' Cash & Equivalents stood at $5.4 million in 2023, then tumbled by 55.37% to $2.4 million in 2024, then soared by 863.39% to $23.0 million in 2025.
• Business Quant data shows BHST's Cash & Equivalents at $23.0 million in Q4 2025, $11.0 million in Q3 2025, and $3.7 million in Q2 2025.